Advances of the Nanotechnology in Targeted Nanomedicines for Treatment of Bone Cancers and Diseases
- Authors
-
-
Fabio Franceschini Mitri
Department of Human Anatomy, Institute of Biomedical Sciences, Federal University of Uberlandia, Uberlandia/MG, Brazil
-
- Keywords:
- Nanotechnology, Nanomedicine, Nanodrugs, Bone Cancer, Osteosarcoma, Bone Infection, Osteoarthritis, Targeted Delivery.
- Abstract
-
The ever-evolving field of nanotechnology has been applied over the years as an amazing potential tool in bone disorders through the development of targeted drug nanosystems. Bone diseases can be referred as any bone condition able to cause morbidity or even mortality to the host. Osteosarcoma has been most investigated condition for management and treatment by nanomedicine, and several nanomaterials such as nanoparticles, nanocapsules, nanospheres, nanodiamonds are being used for drug delivery. Likewise, other bone diseases, such as osteoporosis, osteonecrosis, osteoarthritis, bone tuberculosis have received nanotherapy with a large rate of success. The nanomedicine seems to make up a targeting lack by conventional therapy and chemotherapy, besides appointing to a trend of conservative clinical treatment, especially for severe disorders. Additionally, nanomedicine has advanced over the years, therefore, there is a strong need to accelerate its application in bone diseases reducing the mortality rate related to these conditions. This review article provides an overview on the advances of nanotechnology over the last two decades and highlights the pathways of investigations for targeted delivery nanoensembles.
- Downloads
-
Download data is not yet available.
- Downloads
- Published
- 30-12-2021
- Issue
- Vol. 10 (2021)
- Section
- Articles
How to Cite
Similar Articles
- Sura Findakly, Aiad Gaber Arean, Saba Jesem Alheshemi, Henan Dh. Skheel Aljebori, Dual-Targeting of β-Tubulin and Carbonic Anhydrase IX by Albendazole-Etoricoxib Combination Induces Synergistic Cytotoxicity and Energetic Strangulation in Cervical Cancer Cells , Journal of Cancer Research Updates: Vol. 15 No. 1 (2026)
- Dwight L. McKee, Mamoona S. Lodhi, 43 Natural Anticancer Products: Classified under the Cancer Hallmarks and the Available Evidence of their Anticancer Activities , Journal of Cancer Research Updates: Vol. 10 (2021)
- Tao Xu, Weihong Wei, Zeli Huang, Weihan Hu, Case Report: Coexistence of Non-Keratinizing Squamous Cell Carcinoma and Follicular Lymphoma in Nasopharynx , Journal of Cancer Research Updates: Vol. 3 No. 2 (2014)
- Satoshi Hibi, Kenji Ina, Shu Yuasa, Nobuto Ito, Yuko Shirokawa, Kengo Nanya, Yuko Kato, Takashi Yoshida, Satoshi Kayukawa, Management of Hepatitis B Virus Reactivation after the Completion of Cancer Chemotherapy using a Plan-do-Check-Act Cycle , Journal of Cancer Research Updates: Vol. 11 (2022)
- Altin Goxharaj, Nizom Suyunov, Evgeni Nikolaev, Aliia Bazhanova, Natalia Li, Current Developments and Innovations in Early Detection and Subsequent Treatment of Cancer , Journal of Cancer Research Updates: Vol. 13 (2024)
- Jamison Wijaya, Indrayadi Gunardi, Julvyn Julvyn, Christopher Lim, Benny Nicolas Johannis, Firstine Kelsi Hartanto, Adrianus Rajasa, Rahmi Amtha, Elizabeth Fitriana Sari, Selecting the Appropriate Oral Cancer Cell Line: Characteristic-Based Recommendations from a Systematic Review , Journal of Cancer Research Updates: Vol. 14 (2025)
- Rakesh S. Sankaran, Monu Sarin, Jyoti Prakash Samal, Tarun Parashar, Aashim Dhawan, S. Balaji, Radiopharmaceutical Innovations for Precision Imaging and Treatment of Malignant Tumors , Journal of Cancer Research Updates: Vol. 14 (2025)
- Douglas O. Faigel, Vijay P. Singh, Krutika Patel, Alaa El Chami, Catherine C. Raymond, Tracy L. Landreth, Ronald J. Marler, Douglas F. Lake, Toufic Kachaamy, Safety of Endoscopic-Ultrasound-Guided Portal Injection Chemotherapy using Drug-Eluting Microbeads in a Porcine Model , Journal of Cancer Research Updates: Vol. 7 No. 4 (2018)
- Gregory Russell-Jones, Kirsten McTavish, John McEwan, Bruce Thurmond, Increasing the Tumoricidal Activity of Daunomycin-pHPMA Conjugates Using Vitamin B12 as a Targeting Agent , Journal of Cancer Research Updates: Vol. 1 No. 2 (2012)
- Sandhiya Selvarajan , Melvin George, Suresh Kumar S., Steven Aibor Dkhar, Recent Advances in Cancer Vaccines - An Update , Journal of Cancer Research Updates: Vol. 1 No. 2 (2012)
You may also start an advanced similarity search for this article.